Jeffrey Mellott

Jeff shepherds the on-going strategic alignment of the DeSpir business model for servicing high-risk, high-value transportation solutions with the varying requirements and expectations of its customers. Focusing on the most vulnerable and valuable commodities, including lifesaving pharmaceuticals, biopharma, and gene therapies, Jeff and his team provide expert, proactive guidance to help expedited and cold chain shippers successfully navigate new and emerging market conditions.